Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature

BACKGROUND: Gastrointestinal perforation is known as a serious adverse event, but, for breast cancer, there are very few reports of gastrointestinal perforation. This report highlights gastrointestinal perforation caused by bevacizumab for breast cancer, which is of special interest because gastroin...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Med Case Rep
Hlavní autoři: Fujii, Yusuke, Hirahara, Noriyuki, Kaji, Syunsuke, Taniura, Takahito, Hyakudomi, Ryoji, Yamamoto, Tetsu, Tajima, Yoshitsugu
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2018
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5870367/
https://ncbi.nlm.nih.gov/pubmed/29580267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-018-1619-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky